Page last updated: 2024-10-17

n(1)-acetylspermidine and Graves Disease

n(1)-acetylspermidine has been researched along with Graves Disease in 1 studies

N(1)-acetylspermidine : An acetylspermidine having the acetyl group at the N1-position.

Graves Disease: A common form of hyperthyroidism with a diffuse hyperplastic GOITER. It is an autoimmune disorder that produces antibodies against the THYROID STIMULATING HORMONE RECEPTOR. These autoantibodies activate the TSH receptor, thereby stimulating the THYROID GLAND and hypersecretion of THYROID HORMONES. These autoantibodies can also affect the eyes (GRAVES OPHTHALMOPATHY) and the skin (Graves dermopathy).

Research Excerpts

ExcerptRelevanceReference
" Moreover, pTAb progression to overt hypothyroidism may be related to high N-acetylspermidine."3.91Serum polyamine metabolic profile in autoimmune thyroid disease patients. ( Mao, J; Shan, Z; Song, J; Teng, W, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Song, J1
Shan, Z1
Mao, J1
Teng, W1

Other Studies

1 other study available for n(1)-acetylspermidine and Graves Disease

ArticleYear
Serum polyamine metabolic profile in autoimmune thyroid disease patients.
    Clinical endocrinology, 2019, Volume: 90, Issue:5

    Topics: Adult; Autoantibodies; Disease Progression; Female; Graves Disease; Hashimoto Disease; Humans; Hypot

2019
chemdatabank.com